KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Precigen (PGEN) Operating Expenses (2016 - 2025)

Precigen (PGEN) has disclosed Operating Expenses for 14 consecutive years, with $37.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Operating Expenses rose 68.37% to $37.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$13.6 million, a 109.43% decrease, with the full-year FY2024 number at $1.6 million, down 98.45% from a year prior.
  • Operating Expenses was $37.4 million for Q3 2025 at Precigen, up from $32.6 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $61.6 million in Q2 2024 to a low of -$107.6 million in Q4 2024.
  • A 5-year average of $18.6 million and a median of $24.9 million in 2021 define the central range for Operating Expenses.
  • Peak YoY movement for Operating Expenses: skyrocketed 45768.48% in 2021, then plummeted 403.54% in 2024.
  • Precigen's Operating Expenses stood at -$32.3 million in 2021, then skyrocketed by 173.01% to $23.6 million in 2022, then skyrocketed by 50.47% to $35.5 million in 2023, then tumbled by 403.54% to -$107.6 million in 2024, then surged by 134.76% to $37.4 million in 2025.
  • Per Business Quant, the three most recent readings for PGEN's Operating Expenses are $37.4 million (Q3 2025), $32.6 million (Q2 2025), and $23.9 million (Q1 2025).